Products 2639957-39-2

CAS 2639957-39-2 appears in our catalog under these names: Exarafenib/ 99.26% (existing batch purity), Exarafenib, Exarafenib 98%, Exarafenib, 99.68%, (S)-N-(3-(2-(((R)-1-Hydroxypropan-2-yl)amino)-6-morpholinopyridin-4-yl)-4-methylphenyl)-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, 98%, 98%. Offered by: TargetMol, GLPBio, Ambeed, MedChemExpress, Chemat. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 25 mg, 5 mg.

Exarafenib/ 99.26% (existing batch purity)
TargetMol
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 1023.41
View product
Exarafenib
GLPBio
  • size: 10mg, 100mg, 25mg, 5mg
  • Variants: 5
from 793.62
View product
Exarafenib 98%
Ambeed
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 704.12
View product
Exarafenib, 99.68%
MedChemExpress
  • size: 25 mg, 5 mg, 50 mg, 100 mg
  • Variants: 6
from 1076.66
View product
(S)-N-(3-(2-(((R)-1-Hydroxypropan-2-yl)amino)-6-morpholinopyridin-4-yl)-4-methylphenyl)-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, 98%, 98%
Chemat
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 246.80
View product
Structural formula: {0} (CAS {1})

(3S)-N-[3-[2-[[(2R)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (CAS 2639957-39-2) is a chemical compound with the molecular formula C26H34F3N5O3 and a molecular weight of 521.6 g/mol. IUPAC name: (3S)-N-[3-[2-[[(2R)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide. InChIKey: GZMYLSJUNSCMTD-MOPGFXCFSA-N.

Identity
Molecular formulaC26H34F3N5O3
Molecular weight521.6 g/mol
IUPAC name(3S)-N-[3-[2-[[(2R)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
InChIKeyGZMYLSJUNSCMTD-MOPGFXCFSA-N
SMILESCC1=C(C=C(C=C1)NC(=O)N2CC[C@H](C2)CC(F)(F)F)C3=CC(=NC(=C3)N4CCOCC4)N[C@H](C)CO

Computed by PubChem (NCBI)

Synonyms: Exarafenib, compound 15 [Chen et al., 2024], example 14 [WO2021081375A1], compound 15 (Chen et al., 2024), example 14 (WO2021081375A1), B-Raf Inhibitor KIN-2787, pan-Raf Inhibitor KIN-2787, Exarafenib [INN], Exarafenib?, Exarafenib [WHO-DD]